JP2022529008A5 - - Google Patents

Info

Publication number
JP2022529008A5
JP2022529008A5 JP2021561644A JP2021561644A JP2022529008A5 JP 2022529008 A5 JP2022529008 A5 JP 2022529008A5 JP 2021561644 A JP2021561644 A JP 2021561644A JP 2021561644 A JP2021561644 A JP 2021561644A JP 2022529008 A5 JP2022529008 A5 JP 2022529008A5
Authority
JP
Japan
Prior art keywords
composition according
water
composition
alternatively
absorbing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021561644A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022529008A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/060370 external-priority patent/WO2020212297A1/en
Publication of JP2022529008A publication Critical patent/JP2022529008A/ja
Publication of JP2022529008A5 publication Critical patent/JP2022529008A5/ja
Pending legal-status Critical Current

Links

JP2021561644A 2019-04-15 2020-04-14 長期安定な生存糞便微生物叢組成物 Pending JP2022529008A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19382287 2019-04-15
EP19382287.1 2019-04-15
PCT/EP2020/060370 WO2020212297A1 (en) 2019-04-15 2020-04-14 Long-term stable live fecal microbiota composition

Publications (2)

Publication Number Publication Date
JP2022529008A JP2022529008A (ja) 2022-06-16
JP2022529008A5 true JP2022529008A5 (https=) 2023-04-25

Family

ID=66349477

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021561644A Pending JP2022529008A (ja) 2019-04-15 2020-04-14 長期安定な生存糞便微生物叢組成物

Country Status (19)

Country Link
US (2) US20220143107A1 (https=)
EP (2) EP3955899B1 (https=)
JP (1) JP2022529008A (https=)
KR (1) KR20210152505A (https=)
CN (1) CN113710237B (https=)
AU (1) AU2020259740B2 (https=)
BR (1) BR112021020606A2 (https=)
CA (1) CA3130816A1 (https=)
DK (1) DK3955899T3 (https=)
EA (1) EA202192291A1 (https=)
ES (1) ES3035981T3 (https=)
FI (1) FI3955899T3 (https=)
IL (1) IL287238A (https=)
MX (1) MX2021011246A (https=)
PH (1) PH12021552573A1 (https=)
PL (1) PL3955899T3 (https=)
PT (1) PT3955899T (https=)
SG (1) SG11202110641XA (https=)
WO (1) WO2020212297A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017024265B1 (pt) 2015-05-11 2022-08-09 Mybiotics Pharma Ltd Métodos para crescimento de um biofilme de bactérias probióticas em partículas sólidas
IL294171A (en) 2016-05-25 2022-08-01 Mybiotics Pharma Ltd Composition and methods for microbiota therapy
EP3955899B1 (en) 2019-04-15 2025-05-07 Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) Long-term stable live microbiota composition

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1190386A (en) * 1966-06-28 1970-05-06 Green Cross Corp Process for producing the Lactic Acid Bacteria Drugs
FR2708621B1 (fr) * 1993-07-29 1995-10-20 Lesaffre & Cie Biomasse stable à base de cellules de levure et de bactéries lactiques et procédé de préparation.
ITMI20011632A1 (it) 2001-07-27 2003-01-27 Sanofi Synthelabo Composizione solida contenente spore di batteri non patogeni del genere bacillus
US20050266069A1 (en) 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
CA2623968C (en) 2005-09-29 2014-12-09 Merck Patent Gesellschaft Mit Beschraenkter Haftung Method for stabilising pharmaceutical administration forms comprising microorganisms
DE102005062731A1 (de) * 2005-12-22 2007-06-28 Organobalance Gmbh Neue Lactobacillus Stämme und deren Verwendung
TR200800634A2 (tr) * 2008-01-30 2009-02-23 Takka Sevgi̇ Uzatılmış salım sağlayan fluvastatin tablet.
CA2808610C (en) * 2010-08-10 2018-09-25 R.P. Scherer Technologies, Llc Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria
CN104095180A (zh) * 2013-04-12 2014-10-15 中国科学院烟台海岸带研究所 一种益生菌菊粉片及其制备方法
US10583420B2 (en) * 2014-10-01 2020-03-10 7905122 Canada Inc. Process and apparatus for manufacturing water-absorbing material and use in cat litter
WO2016178775A1 (en) * 2015-05-01 2016-11-10 Microbiome Health Research Institute Inc. Compositions and methods for therapeutic delivery of microbial communities
CN104922158B (zh) * 2015-06-05 2018-11-02 中国人民解放军第三军医大学第三附属医院 粪菌胶囊及其制备与应用
US10905726B2 (en) 2015-06-09 2021-02-02 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
CN109414048B (zh) * 2016-06-30 2023-09-01 弗门尼舍有限公司 包衣酵母配方
US20200147151A1 (en) * 2017-01-30 2020-05-14 The Board Of Regents Of The University Of Texas System Compositions and methods for fecal microbiota transplantation
US20200188310A1 (en) 2017-08-29 2020-06-18 Chr. Hansen A/S Stable capsules with fecal microbiota or a culture of microorganisms
CN108567799A (zh) * 2018-08-01 2018-09-25 中国人民解放军总医院 一种全粪菌复合胶囊及其制备方法和应用
EP3955899B1 (en) 2019-04-15 2025-05-07 Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) Long-term stable live microbiota composition

Similar Documents

Publication Publication Date Title
JP2022529008A5 (https=)
RU2013110820A (ru) Применение связывающих средств для получения стабильных при хранениии составов
JPS63258808A (ja) 徐放性製剤
RU2008137032A (ru) Распадающиеся пероральные пленки
AR075735A1 (es) Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso
HRP20240564T1 (hr) Novi farmaceutski sastav
EA014249B1 (ru) Формуляция леветирацетама длительного высвобождения
JP2013545762A5 (https=)
JPH02221219A (ja) 接着性錠剤
BRPI0710682A2 (pt) combinação farmacêutica consistente de 3 - (3-dimetilamino-1-etil-2-metil-propil)-fenol e paracetamol
RU2012100709A (ru) Новые фармацевтические композиции, содержащие прегабалин
AR061166A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilferina
CN103889406A (zh) 一种口腔崩解片及其制备方法
CA2633924A1 (en) Gastric reflux resistant dosage forms
FI3955899T3 (fi) Pitkäaikaisesti vakaa, elävä mikrobiotakoostumus
RU2008147216A (ru) Жидкая лекарственная композиция
US3211614A (en) Enema-type laxative composition
BRPI0613547A2 (pt) forma de dosagem de liberação modificada e respectivo uso
PT1305057E (pt) Composicao de biomateria microparticular para uso medicinal
JP3759949B2 (ja) 遮光剤及び皮膜組成物
JP2007529564A5 (https=)
JP2011521942A (ja) ユーフォルビア・プロストラータを含有する組成物およびその調製方法
CN104069114A (zh) 前列地尔口腔制剂
NO20055601L (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
BR102014022486B1 (pt) Processo de purificação de extrato de jambu, extrato purificado assim obtido,composição anestésica e bioadesivo contendo extrato purificado de jambu; eusos